US11504407B2ActiveUtilityA1

Bifidobacterium genus bacterium

60
Assignee: MORINAGA MILK INDUSTRY CO LTDPriority: Mar 28, 2017Filed: Mar 23, 2018Granted: Nov 22, 2022
Est. expiryMar 28, 2037(~10.7 yrs left)· nominal 20-yr term from priority
Inventors:Takuma SakuraiNanami HashikuraKanetada ShimizuSachiko TakahashiAyako Horigome
A61K 35/745C12N 1/20A23L 33/135A23V 2002/00A23C 9/1234C12R 2001/01C12N 1/205A23L 33/40A23Y 2300/55A23Y 2300/25A23V 2400/517A23V 2400/533
60
PatentIndex Score
0
Cited by
25
References
11
Claims

Abstract

Novel Bifidobacterium bacteria having an opioid peptide decomposition action and a noncollagenous glycoprotein decomposition action are provided. The present invention relates to one or more kinds of Bifidobacterium bacteria selected from the group consisting of Bifidobacterium bifidum MCC1092 (NITE BP-02429), Bifidobacterium bifidum MCC1319 (NITE BP-02431), Bifidobacterium bifidum MCC1868 (NITE BP-02432), Bifidobacterium bifidum MCC1870 (NITE BP-02433), and Bifidobacterium longum subsp. longum MCC1110 (NITE BP-02430), as well as a composition for decomposing an opioid peptide and composition for decomposing a noncollagenous glycoprotein containing the Bifidobacterium bacteria as an active ingredient.

Claims

exact text as granted — not AI-modified
The invention claimed is: 
     
       1. A cell powder comprising  Bifidobacterium  bacteria that has been dried, wherein the  Bifidobacterium  bacterium is  Bifidobacterium longum  subsp.  longum  MCC1110 deposited with the National Institute of Technology and Evaluation under the accession number (NITE BP-02430). 
     
     
       2. A method for decomposing an opioid peptide selected from the group consisting of β-casomorphin, gliadorphin, and combinations thereof, which comprises administering to a subject in need thereof a composition comprising the cell powder of  claim 1 . 
     
     
       3. A method for decomposing a noncollagenous glycoprotein selected from the group consisting of fibrin, fibrinogen, fibronectin, laminin, and plasminogen, which comprises administering to a subject in need thereof a composition comprising the cell powder of  claim 1 . 
     
     
       4. The cell powder of  claim 1 , which has been further triturated. 
     
     
       5. The cell powder of  claim 1 , wherein the  Bifidobacterium  bacteria comprises live cells and/or dead cells; and the amount of  Bifidobacterium  bacteria present in the cell powder is 10 6  (cfu and/or cells)/gm or more. 
     
     
       6. The cell powder of  claim 5 , wherein the amount of  Bifidobacterium  bacteria present in the cell powder is 10 12  (cfu and/or cells)/gm or less. 
     
     
       7. The cell powder of  claim 1 , wherein the  Bifidobacterium  bacteria comprises live cells and/or dead cells. 
     
     
       8. A food comprising the cell powder of  claim 1 . 
     
     
       9. Milk obtained by fermenting milk with the cell powder of  claim 1 . 
     
     
       10. Infant formula comprising the cell powder of  claim 1  dissolved therein. 
     
     
       11. A drink comprising the cell powder of  claim 1  dissolved therein.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.